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Genetic counselingAbstract Background: Sex determination and differentiation in humans are processes that involve
the interaction of several genes such as SRY, SOX9 genes which are important in the development
of the male genital system. Also NR5A1 gene plays an important role in the development of gonads
and the adrenal glands. Aim of the study include clinical assessment of children with disorders of
sex development, molecular analyses for SRY, SOX9 and NR5A1 genes and genetic counseling
for the patients and their families.
Subjects and methods: This study included sixteen patients from 1 day to 6 years old attending
the Genetics and Endocrinology unit, Pediatric department, Faculty of Medicine, Menouﬁya
University, Egypt. All cases were subjected to: detailed history, thorough clinical examination, rou-
tine and hormonal investigations, imaging studies, cytogenetic and molecular studies for SRY,
SOX9 and NR5A1 genes.
Results: Positive consanguinity between the parents was detected in seven patients (43.75%).
Serum 17 OH progesterone was elevated in ﬁve patients (31.25%) and below normal ranges in
two patients (12.5%). Cytogenetic study revealed six patients with normal (46, XX) karyotype, eight
patients with normal (46, XY) karyotype, one patient had (45, X) karyotype and another with (45,
X/46, XY) karyotype. Thirteen out of sixteen patients undergone molecular studies, SRY gene was
+ve for six patients with normal male (46, XY) undergone and one patient with (45, X) karyotype
(translocated SRY). SRY was ve for ﬁve patients with normal female (46, XX) karyotype and one
patient with (45, X/46, XY) karyotype (deleted SRY). All patients were +ve for SOX9 and NR5A1
genes and no deletions detected.
Conclusion: Genetic studies beside clinical and hormonal evaluation will allow us to rapidly
reach a diagnosis and to identify a ‘molecular sex’ for each patient.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Ain Shams University. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Molecular mechanisms of sex determination involve a growing
network of genes, a large number of which are transcription
factors. The transcription factors so far identiﬁed as having a
major role in sex determination, namely SRY, SOX9 and
246 S.S. AboElella et al.NR5A1, can be disrupted by a number of mutations that can
affect either their availability in the nucleus or their function [1].
Steroidogenic factor 1 (SF1), denominated as nuclear
receptor subfamily 5 group A member 1 is a protein that reg-
ulates several steps of adrenal and gonadal development. It is
encoded by the NR5A1 gene, which is an autosomal gene
mapped to 30 kb within 9q33. NR5A1 is expressed in the
developing urogenital ridge, steroidogenic tissues (such as
gonads, adrenals, and placenta), hypothalamus and anterior
pituitary [2].
In general, it activates the expression of anti-mullerian hor-
mone (AMH) in sertoli cells leading to the regression of
Mu¨llerian structures and in leydig cells, it activates the expres-
sion of several enzymes involved in steroidogenesis, resulting
in the virilization of external genitalia and testicular descent.
In ovaries, NR5A1 is expressed in the granulosa and theca
cells where it regulates genes required for ovarian steroido-
genesis and follicle growth maturation [3]. Therefore, muta-
tions in NR5A1 may lead to disorders of sex development
(DSD) deﬁned as incomplete or disordered gonadal or genital
development, causing divergences between genetic sex, gonadal
sex and phenotypic sex [4].
The objective of this study is clinical assessment of children
with ambiguous genitalia, molecular analyses for SRY, SOX9
and NR5A1 genes and genetic counseling for the patients and
their families.
2. Patients and Methods
2.1. Patients
The study was conducted on sixteen patients with ambiguous
genitalia. They were selected from Genetics and Endocrine
Unit, Pediatric department, Menouﬁya university hospitals,
Egypt. They were seven apparent female patients and nine
apparent male patients. Their ages ranged from the 1 day to
6 years old.
2.2. Methods
All studied patients were subjected to the following:
1. A detailed history including maternal diseases resulting in
virilization as (maternal luteomas), exposure to androgens
and endocrine disrupters (phenytoin). Consanguinity,
recurrent miscarriages, unexplained infant death and
neonatal history of failure to thrive, vomiting, skin pigmen-
tations and progressive virilisation were reported [5].
2. A thorough physical examination of studied patients (vital
signs, anthropometric measurements, other congenital
abnormalities, dysmorphic features, hirsutism or abnormal
body pigmentations) was also reported [6].
3. A careful examination of the external genitalia of studied
infants includes:-
a. Size of phallus.
b. Examination for the testes in apparent male patients
(palpable or not, their size, location, and texture).
c. Prader score application for degree of virilization in
apparent female cases [7].
d. Calculating the External Masculinisation Score (EMS)
in male cases [8].4. Tanner staging system for pubertal changes [9].
5. Routine investigations included complete blood picture,
serum electrolytes especially (Na and K) and glucose levels
for cases with salt losing congenital adrenal hyperplasia
(CAH) [10].
6. Hormonal studies involved serum levels of 17 hydroxy pro-
gesterone, cortisol, adrenocorticotropic hormone, testos-
terone, dihydrotestosterone, dehydroepiandrosterone, and
androstendione according to suspected diagnosis and inter-
preted in relation to speciﬁc reference ranges [11].
7. Imaging studies including abdominopelvic ultrasonogra-
phy, CT and or MRI for visualization of the internal geni-
talia, gonadal site and structure if present. [12].
8. Genetic studies including
a. Cytogenetic analysis (chromosomal karyotyping) was
performed on peripheral blood from the patients’ lym-
phocytes that were cultured according to the standard
method. Banding patterns were analyzed [13]
b. Molecular studies for detection of absence or presence
of gene products for SRY, SOX9 and NR5A1 genes.
The following steps were applied:
1. DNA extraction from blood samples: Genomic DNA
was extracted from peripheral blood samples using
Thermo Scientiﬁc GeneJET PCR Puriﬁcation Kit
(# K0721 made in EU. Lithuania) that utilizes a pro-
prietary silica-based membrane technology in the
form of a convenient spin column according to
manufacturer’s instructions.
2. Polymerase Chain Reaction: Each PCR reaction was
performed with mixture consisted of 0.2 lg of genomic
DNA, 2.5 U of Taq DNA polymerase, 0.5 lmol/L of
each primer, 100 mmol/L dNTPs, 3.0 mM MgCl2
and 1· PCR buffer in a ﬁnal volume of 50 ll. The
PCR conditions were 5 min at 94 C for pre-heating,
35 cycles of 94 C for 30 seconds, 57 C for 30 seconds
and 72 C for 1 min, and 72 C for 10 min post-exten-
sion using an automated thermal cycler (Bio-Rad MJ
Research PTC-200 DNA Engine thermal cycler).
3. Primer sequences of studied genes were as follows:Gene Forward primer Reverse primer
SRY 50-GAATATTCCCG
CTCTCCGGAG-30
50-ACCTGTTGT
CCAGTTGCACT-30
SOX9 50-TATGACTGG
ACCCTGGTG-30
50-TGTGGCTTGT
TCTTGCTGG-30
NR5A1 50-CCGCAGCATT
ACCAACACCACA-30
50-CATCCGTGCT
TTATCCTGAGCTG-304. Reaction products were electrophoresed on 3% agarose–
TBE gels containing 0.5 lg/ml ethidium bromide and
DNA bands visualized under UV light, and their positions
determined in relation to DNA ladders (Thermo Scientiﬁc
GeneRuler 50 bp and 100 bp DNA Ladders).
9. Genetic counseling was done for all families including clin-
ical aspects and diagnostic approach about the child condi-
tion with the parents, information on available options and
determining methods for communication and follow up.
Molecular study of developmental sex disorders in children 24710. Informed consent was taken from parents of the chil-
dren. The study was approved by the ethical committee
of Menouﬁya University. The work has been carried out
in accordance with the code of Ethics of the World
Medical Association (Declaration of Helsinki) for
experiments in humans.
3. Results
The present study includes sixteen patients aged from 1 day to
6 years. Their presenting manifestations varied between
ambiguous genitalia, salt losing attacks, abnormal body pig-
mentations and hair growth and urine stream abnormalities.
Demographic data of studied patients: seven patients
(43.75%) had consanguineous parents. In addition, patients
(14 & 15) were cousins. Five patients (31.25%) had possible
similar conditions in their families (Table 1). Anthropometric
measurements showed that four patients (25%) were below
3rd percentile for weight and below <2 SD for BMI and
three of them were below 3rd percentile for length.
The external genital manifestations of the female patients
(Table 2) were mainly clitoromegaly and fused labia, with no
palpable gonads and two of them had abnormal pubic hair
growth. Prader score for apparent female patients: three had
score of 1, two had score of 2 and another two patients had
score of 4. The external genital manifestations of the male
patients were mainly biﬁd scrotum and urethral opening at
phallus base. Three had microphallus. Two had only one pal-
pable gonad and one patient number (12) looked apparently
female (Table 3).
External masculinization score was applied to male
patients, and all nine patients were involved and their total
scores were below normal score (P11). Tanner staging system
showed that all patients are in 1st pubertal stage except two
female patients (4 & 16) who were with pubic hair stage 2.
Serum electrolytes and blood glucose levels were within
normal levels in all patients except in three patients (2, 12 &
14) who had hyperkalemia and hyponatremia, and only two
of them (12 & 14) suffered from hypoglycemia.
Hormonal evaluation revealed that ﬁve patients (31.25%)
had above normal ranges for serum 17 OH progesterone levels
and two (12.5%) had below normal ranges. From these seven
patients, six had elevated serum ACTH levels and low serum
cortisol levels. Mean serum 17 OH progesterone level for all
cases was: 321.25 ± 603.57 ng/dl SD. Mean serum ACTH
levels were, Am: 101.56 ± 88.2 pg/ml, Pm: 59.3 ± 51.98
pg/ml. Mean serum cortisol levels were, Am: 11.1 ± 8.31 ug/
dl, Pm: 10.87 ± 7.5 ug/dl.
Imaging studies revealed that all genetic female patients
had internal female genitalia except patient (6) with (45, X)
karyotype. Clinically, this patient had biﬁd scrotum with pal-
pable right testis and his phallus was 2.5 cm in length and
imaging studies showed no internal female genitalia, right scro-
tal testis and left inguinal one.
All genetic male patients showed no internal female genital-
ia except patient 7 with 45, X/46, XY karyotype who showed
uterus and bilateral pelvic streak gonads. Clinically, this
patient was an apparent female on external genitalia with cli-
toromegaly, fused labia, identiﬁed vaginal and urethral oriﬁces
and no palpable gonads (tables 2 and 3).Cytogenetic studies showed six female patients with (46,
XX) DSD, eight male patients with (46, XY) DSD, one had
45, X and another with 45, X/46, XY.
Regarding molecular studies, SRY products were detected
at 418 bp position and SOX9 products at 270 bp compared
to 100 bp DNA ladder on gel electrophoresis. NR5A1 prod-
ucts were detected at 50 bp compared to 50 bp DNA ladder
on gel electrophoresis. We must note that the molecular studies
were performed for all patients except patients 4, 11 and 13
who refused sample withdrawal.
Results for SRY gene revealed that patient 6 with 45, X
karyotype had a translocated SRY gene and patient 7 with
45, X/46, XY karyotype had a deleted SRY (Figs. 3 and 4).
SOX9 and NR5A1 genes were present in all studied patients
and no deletions detected (Figs. 5–8).
Genetic counseling was done through frequent sessions and
included:
1. Discussing clinical aspects and diagnostic approach about
the child’s condition with the parents and its importance
before rushing to gender selection.
2. Documentation of family history and pedigree information.
3. Consent for photography and blood sample withdrawal.
4. Recognition of inheritance patterns and risk estimation
about the disease if with genetic basis.
5. Information of available options to help making informed
medical and personal decisions.
6. Determining methods for communication and follow up.
4. Discussion
In the present study the ages of our patients ranged from 1 day
to 6 years old with mean for age of presentation
2.2 ± 3.3 months, the commonest age of presentation was
the neonatal period (11 cases; 68.75%), followed by infancy
with ﬁve cases (31.25%). In agreement to our results,
Hughes [14] reported that DSD typically are diagnosed at birth
in infants with ambiguous genitalia while, disorders associated
with phenotypic males and females may be diagnosed much
later.
Five patients had possible similar conditions in their families
and two of them were cousins. This was consistent with the
approach taken by Clayton et al. [15], who documenting that
a family pedigree is an essential step in management of DSD
and associated genetic counseling.
Seven patients (43.75%) had a positive consanguineous
parent and patients (14 & 15) were cousins. This was consistent
with a study conducted by Mazen et al. [16] which showed con-
sanguinity rate of 61% in the affected families with DSD. Not
forgetting that CAH is autosomal recessive, so the high preva-
lence of consanguinity in our cases is a signiﬁcant risk factor in
DSD cases, which was also reported by Nimkarn [17].
Presenting manifestations included ambiguous genitalia,
salt-losing crisis in three patients, abnormal body hair growth
in two female patients, abnormal body pigmentations in one
female patient and abnormal urine stream in two apparent
male patients. These presentations were in line with Warne
and Raza [18] who reported that the signs of DSD vary from
being not recognized at all as in cases with non salt-losing
CAH, to being completely ambiguous external genitalia.
Table 1 Demographic data of the studied patients.
Serial
No.
Age at
examination
Age of
clinical
presentation
Birth
order
Maternal
age (yrs)
Paternal
age (yrs)
Consanguinity Maternal
and obstetric
history
Family
history
Pedigree
1 2 yrs 1 day 2nd 23 27 +ve
2 4 mth 1 day 3rd 25 26 +ve 1st sibling died at
6 months old with
vomiting attack
(similar condition)
3 2 mth 1 day 1st 20 32 ve
4 30 mth 5 mth 2nd 23 33.5 +ve
5 10 mth 3 mth 5th 38 49 +ve 1st sibling died at
age of 3 years with
similar condition
6 1 day 1 day 2nd 27 32 ve
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Table 1 Demographic data of the studied patients.
Serial
No.
Age at
examination
Age of
clinical
presentation
Birth
order
Maternal
age (yrs)
Paternal
age (yrs)
Consanguinity Maternal
and obstetric
history
Family
history
Pedigree
7 18 mth 1 day 3rd 29.5 32.5 ve
8 20 mth 1 day 4th 40 46 ve Previous
2 abortions.
9 30 days 1 day 1st 25 31 ve
10 1 day 1 day 1st 22 25 ve
11 1 day 1 day 4th 36 40 +ve Similar ondition in
his elde brother
12 1 yr 3 wk 1st 20 25 ve
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Table 1 Demographic data of the studied patients.
Serial
No.
Age at
examination
Age of
clinical
presentation
Birth
order
Maternal
age (yrs)
Paternal
age (yrs)
Consanguinity Maternal
and obstetric
history
Family
history
Pedigree
13 2 days 1 day 2nd 23 28 ve
14 5 mth 4.5 mth 5th 37 41 +ve Previous
2 abortions.
– Dead elder sister
by a similar
condition and living
cousin.
–Three abortions in
her cousin’s mother
15 6 yrs 4 mth 1st 30 36 ve Previous 3
abortions,
two before and
one after her birth
– One living cousin
and another dead
one.
– Two abortions
with her cousin’s
mother.
16 1 yr 11 mth 1st 19 28 +ve
mth, month; yrs, years.
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Table 2 Data summary of apparent female patients: (7 patients).
Serial
No.
Presentation
diagnosis
Local examination Serum K
level
Hormonal investigations Imaging studies Karyotyping SRY
gene
SOX9and
NR5A1
genes
Diagnosis
ACTH (pg/ml) Cortisol (lg/dl) 17 OHP
(ng/dl)
Others
Am Pm Am Pm
2 Ambiguous genitalia
and recurrent attacks
of vomiting
Genitalia shows
– Clitoromegaly (3.75 cm)
– Fused labia with single
vestibule
– No palpable gonads
5.5 › 215 › 78 › 1.6 ﬂ 1.9 ﬂ 2000 › DHEA 84.5 ng/dL › Internal female
genital organs
46 XX ve +ve CAH
4 Large clitoris and
abnormal hair growth
Genitalia shows
– Clitoromegaly (3.5 cm)
– Fused labia with identiﬁed
urethral and vaginal oriﬁces,
– Scanty pubic hair
– No palpable gonads
5 166 › 92 › 1.5 ﬂ 2.1 ﬂ 358 › DHEA 87 ng/dL ›
and androstendione
53 ng/dl ›
Internal female
genital organs and
ovaries
46 XX – – CAH
5 Large clitoris Genitalia shows
– Clitoromegaly(2.7 cm)
– Fused labia with urethral
opening like penile
hypospadias
– No palpable gonads
3.7 264 › 115 › 1.4 ﬂ 1.7 ﬂ 1684 › Androstendione
47.3 ng/dl › and free
testosterone 0.4 ng/dl
›
Internal female
genital organs
46 XX ve +ve CAH
7 Large clitoris Genitalia shows
– Clitoromegaly(3 cm)
– Fused labia with identiﬁed
vaginal and urethral oriﬁces
– No palpable gonads
4.5 29 18 10.5 11.6 35 Uterus and ectopic
kidneyand bilateral
steak gonads
45X/46 XY ve +ve Mixed
gonadal
dysgenesis
14 Dehydration attack Genitalia shows
– Clitoromegaly (1.3 cm)
– No fused labia with identiﬁed
vaginal and urethral oriﬁces
– No palpable gonads
6 › 267 › 217 › 1.4 ﬂ 1.8 ﬂ 10 ﬂ DHEA 96 ng/dL ›
and androstendione
3.5 ng/dl ﬂ
Internal female
genital organs
46 XX ve +ve CAH
15 Abnormal body
pigmentations and
clitoromegaly
Genitalia shows
– Clitoromegaly (1.6 cm)
– No fused labia with identiﬁed
vaginal and urethral oriﬁces
– No palpable gonads
3.9 136 › 75 › 1.9 ﬂ 2.2 ﬂ 254 › DHEA 152 ng/dL › Internal female
genital organs
46 XX ve +ve CAH
16 Abnormal body hair
growth
Genitalia shows
– Clitoris about 0.9 cm in
length
– No fused labia, with
identiﬁed vaginal and urethral
oriﬁces
– and no palpable gonads
4.7 28 31 19.4 17.6 32 Normal DHEA and
androstendione levels
Internal female
genital organs
46 XX ve +ve Idiopathic
hirsutism
CAH; congenital adrenal hyperplasia, 17 OHP; 17 OH progesterone.
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Table 3 Data summary of apparent male patients: (9 patients).
Serial
No.
Presentation Local examination Hormonal assays Imaging studies Karyotyping SRY
gene
SOX9 and
NR5A1F
gene
Diagnosis
ACTH (pg/ml) Cortisol (lg/dl) 17 OHP
(ng/dl)
Others
Am Pm Am Pm
1 Ambiguous genitalia Genitalia shows
– 2 palpable gonads
– Phallus about 3 cm in length
– Biﬁd scrotum with urethral opening
at phallus base
44 27 11.7 13.1 198 › DHEA 14 ng/dl ﬂ,
androstendione 3.5 ng/dl ﬂ
and free testosterone
0.16 ng/dl ﬂ
No internal female organs
and bilateral labioscrotal
gonads
46 XY +ve +ve CAH
3 Ambiguous genitalia Genitalia shows
– 2 palpable gonads (1x 1 cm)
– Phallus about 2.75 cm from ventral
aspect
– Biﬁd scrotum with hypospadias
33 21 15 17 66 Free testosterone 2.16 ng/dl
› and Total 326 ng/dl ›,
DHT 0.3 ng/dl ﬂ
T: DHT ratio 7.2 and after
hCG was 37.4
No internal female genital
organs and bilateral
labioscrotal gonads
46 XY +ve +ve 5 a reductase deﬁciency
6 Ambiguous genitalia Genitalia shows
– Palpable Rt testis (1.5 x 1 cm)
– Phallus about 2.5 cm
– Biﬁd scrotum with urethral opening
like hypospadias
41 33 20.1 19 55 Free testosterone 1.3 ng/dl
and DHT 22 ng/dl
No internal female genital
organs, Rt scrotal testis and
Lt inguinal one
45 X +ve +ve 45 X male syndrome
8 Abnormal urine
stream
Genitalia shows
– 2 palpable gonads
– Phallus about 3.75 cm in stretched
length
– Biﬁd scrotum with urethral opening
at base of phallus and scrotum
48 26 21 20 103 No internal female genital
organs and bilateral
labioscrotal gonads
46 XY +ve +ve Penioscrotal hypospadias
9 Ambiguous genitalia Genitalia shows
– 2 palpable gonads
– Phallus (3.2 cm) with longitudinal
groove on ventral aspect
– Urethral opening at base of phallus
associated with biﬁd scrotum
55 44 19.8 18.7 70 No internal female genital
organs and bilateral
labioscrotal gonads
46 XY +ve +ve Penioscrotal hypospadias
10 Ambiguous genitalia
and respiratory
distress
Genitalia shows
– 2 palpable gonads
– Phallus (3 cm) with longitudinal
groove on ventral aspect
– Urethral opening at base of phallus
associated with biﬁd scrotum
52 28 17.4 12.5 89 No internal female genital
organs and bilateral
labioscrotal gonads
46 XY +ve +ve Penioscrotal hypospadias
11 Ambiguous genitalia
and abnormal urine
stream
Genitalia shows
– 2 palpable gonads
– Phallus (1 cm) with longitudinal
groove on ventral aspect
– Urethral opening at base of phallus
associated with biﬁd scrotum
39 34 22 19.2 94 No internal female genital
organs and bilateral
labioscrotal gonads
46 XY – – Penioscrotal hypospadias
and micropenis
12 Vomiting and
dehydration attack
– Female like external genitalia
– Shows 2 palpable gonads
– Phallus (1.5 cm) with a single
opening at its base on ventral aspect
178 › 88 › 2 ﬂ 2.2 ﬂ 17 ﬂ DHEA 17.7 ng/dl ﬂ,
androstendione 2.8 ng/dl ﬂ
and total testosterone
0.2 ng/dl ﬂ
No internal female genital
organs and Rt inguinal testis
and Lt labioscrotal one
46 XY +ve +ve CAH
13 Ambiguous genitalia Genitalia shows
– Left palpable gonad,
– Phallus (2 cm)
– Urethral opening at base of phallus
associated with biﬁd labioscrotal folds
30 22 11.3 13.3 75 No internal female genital
organs and Rt inguinal, Lt
labioscrotal gonads
46 XY – – Penioscrotal hypospadias
and micropenis
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Figure 1 External genitalia of patient number (6).
Figure 2 External genitalia of patient number (7).
Figure 3 Gel electrophoresis of SRY gene in apparent male
cases: First lane on the left shows 100 bp DNA ladder. SRY was
present at position 418 bp in all clinically apparent male cases
including case number (6) which had a karyotype of 45, X (with
translocated SRY gene).
Figure 4 Gel electrophoresis of SRY gene in apparent female
cases: First lane on the left shows 100 bp DNA ladder. F = female
control and M=male control. Clinically apparent female cases
showed no bands for SRY gene including case number (7) which
had a karyotype of 45, X/46, XY(with deleted SRY gene).
Molecular study of developmental sex disorders in children 253As regards the anthropometric measurements, all patients
were within normal ranges except in 4 cases which were below3rd percentile for weight and <2 SD for BMI, and only three
of them were below 3rd percentile for length. This is consistent
Figure 5 Gel electrophoresis SOX9 gene in apparent male cases:
First lane on the left shows 100 bp DNA ladder. SOX9 was
present at position 270 bp in all clinically apparent male cases.
Figure 7 Gel electrophoresis of NR5A1 gene in apparent male
cases: First lane on the left shows 50 bp DNA ladder. NR5A1 gene
for apparent male cases was detected approximately at 50 bp
position.
254 S.S. AboElella et al.with the signiﬁcance of serial anthropometric measurements as
an important tool to insure that DSD especially salt losing
CAH do not affect the child normal growth pattern and for
follow up of treatment [19].
The external genital manifestations of the female patients
were mainly clitoromegaly and fused labia, with no palpable
gonads and two of them had abnormal pubic hair growth.
Prader score for the apparent female patients in this study ran-
ged from score 1 to score 4. These ﬁndings were consistent with
the ﬁndings of Ogilvy-Stuart and Brain [20], who demonstrat-
ed that any apparent female case with DSD may present with a
wide range of presentations.
For male patients, the external genital manifestations were
mainly biﬁd scrotum and urethral opening at phallus base.
Three cases had microphallus. Two had only one palpable
gonad and one case looked apparently female (patient number
12). In addition, the external masculinization score (EMS),
which is used to describe the degree of ambiguity in an
undervirilized boy, was applied and all male cases scored
below 11, which mean that they need to be evaluated carefully
for possibility of DSD [8].
Tanner staging showed that all patients are in 1st pubertal
stage except two female patients (4 and 16) who were with
pubic hair stage 2 which was consistent with the early age ofFigure 6 Gel electrophoresis of SOX9 gene in apparent female
cases: First lane on the left shows 100 bp DNA ladder. F = female
control and M=male control. SOX9 was present at position
270 bp in all clinically apparent male cases.presentation and evaluation in majority of our cases depending
on etiological nature of the disease. This demonstrated the
dependency of Tanner stages on hormonal effects as regards
secondary sexual characteristics [21].
Regarding the imaging studies, seven patients with appar-
ent female phenotype had normal mullerian structures and
gonads except case 7 who had bilateral pelvic streak gonads.
Nine patients with apparent male phenotype showed normal
inguinoscrotal gonads and no internal female genitalia.
These ﬁndings were in line with Govind et al. [22] illustrations
about imaging of ambiguous genitalia, and dependency of the
results on the etiological nature of the disease.
Considering hormonal studies, we found that ﬁve patients
were above normal ranges for serum 17 OH progesterone
levels and two patients were below normal ranges. From these
seven patients, six had elevated serum ACTH levels and low
serum cortisol levels. In addition, ﬁve of them showed elevated
serum adrenal androgen levels, and the other two showed
decreased levels. This was consistent with the laboratory ﬁnd-
ings of CAH as demonstrated by Wajnrajch and New [23],
indicating the cornerstone role of the measurement of these
three hormones especially 17-OHP for establishing diagnosis
of CAH.Figure 8 Gel electrophoresis of NR5A1 gene in apparent female
cases: First lane on the left shows 50 bp DNA ladder. F/
C = female control. NR5A1 gene for these cases was detected
approximately at 50 bp position.
Molecular study of developmental sex disorders in children 255Four female patients (2,4,5,15) had elevated serum17
hydroxy progesterone level, low serum cortisol and high
ACTH levels and elevated DHEA and androstendione levels,
which is consistent with diagnosis of CAH due to 21 hydroxy-
lase deﬁciency, the most common cause of CAH [15].
For patient number 1, we found mildly elevated serum17
hydroxy progesterone level, normal serum cortisol and
ACTH levels and low DHEA and androstendione levels,
which is consistent with diagnosis of CAH due to isolated
17,20-lyase deﬁciency [24].
Considering patient number 14, hormonal evaluation
demonstrated low serum17-OHP level and cortisol levels,
elevated serum ACTH levels, elevated serum DHEA level
and low serum androstendione level, which is consistent
with laboratory ﬁndings in cases with CAH due to
3-Hydroxysteroid Dehydrogenase deﬁciency [25].
Regarding patient number 12, hormonal evaluation showed
decreased serum17-OHP, serum cortisol levels with elevated
serum ACTH levels and low adrenal androgens levels. These
ﬁndings were consistent with laboratory ﬁndings in cases with
salt losing CAH due to 20-22 desmolase deﬁciency [26].
As regards other hormonal assays depending on the case,
we found that patient number 3 showed high serum testos-
terone levels, low serum DHT level and high T:DHT ratio
(37.4) after hCG stimulation test. Being with normal male
karyotype, these ﬁndings were consistent with diagnosis of 5
a reductase deﬁciency [27].
The genetic study was divided into two main categories:
karyotyping and molecular study. Karyotyping of the cases
revealed six patients (37.5%) had normal female (46, XX)
karyotype, eight patients (50%) with normal male (46, XY)
karyotype and two (12.5%) with abnormal karyotypes (one
with 45, X and another with 45, X/46, XY). This was consis-
tent with Siklar et al. [28] who showed that 51.4% of cases with
DSD had 46, XY karyotype, 34.9% with 46, XX and 13.7%
with other conditions, and considering the limitations in our
data collection may have led to estimation of less than the usu-
al variation expressed by other authors. This also conﬁrmed
the essentiality of karyotyping for provisional diagnosis and
classiﬁcation of the DSD cases [10].
Regarding molecular study, we focused on three genes
SRY, SOX9 and NR5A1 genes. Mutations or deletion of
SRY gene can result in 46, XY sex reversal or gonadal dys-
genesis [29] while translocation of Y chromosomal material
including SRY gene can result in 46, XX male syndromes
[30]. Deletion or mutations of SOX9 gene can result in a severe
skeletal malformation syndrome (campomelic dysplasia) which
is frequently associated with male to female sex reversal [31]. In
humans, abnormalities in SF1 (NR5A1) gene can lead to adre-
nal and gonadal failure, severe penoscrotal hypospadias and
sex reversal [32].
Regarding SRY gene, we detected SRY gene band at
418 bp position (Figs. 3 and 4) in all studied genetically male
patients except patient number 7 which had a karyotype of
45, X/46, XY. Also for studied genetically female patients,
no SRY gene bands were detected except patient number 6
which had a karyotype of 45, X. This is in line with role of
SRY gene in sex determination towards a male line through
the presence of Y chromosome or its translocation to another
chromosome mostly X chromosome [30].
As regards SOX9 gene, the results demonstrated the pres-
ence of SOX9 gene band nearly at 270 bp position in all cases(Figs. 5 and 6). Therefore, no deletions for SOX9 gene were
detected in our studied cases and this was in line with clinical
manifestations of studied cases in which no single case showed
skeletal malformation.
As regards NR5A1 gene, the results demonstrated the pres-
ence of NR5A1 gene band nearly at 50 bp position in all
patients (Figs. 7 and 8). Therefore, no deletions for NR5A1
gene were detected in our studied patients. This may be due to
small sample size and the presence of microdeletions and muta-
tions that need more advanced techniques as gene sequencing.
Regarding patient number 6 who presented to us with
ambiguous genitalia from the 1st day of life. Local examina-
tion showed biﬁd scrotum with only palpable right testis and
phallus 2.5 cm in length with proximal hypospadias (Fig. 1).
Imaging studies conﬁrmed the presence of right scrotal testis,
left inguinal gonad and absence of Mullerian structures.
Hormonal evaluation was normal for adrenal and testicular
functions. These results were consistent with being undermus-
culinized male, but cytogenetic studies including Fluorescent
insitu hybridization revealed a case of 45, X. This directed
evaluation toward the possibility of a translocated SRY gene,
and the molecular study for SRY gene revealed its presence in
this case (Fig. 3) as reported in other studies [33].
Patient number 7 was clinically an apparent female on
external genitalia and stage 2 on Prader scale (Fig. 2).
Laboratory evaluation was normal and imaging studies includ-
ing MRI showed uterus and bilateral pelvic streak gonads.
These results were consistent with being virilized female, but
cytogenetic studies including FISH revealed a case of 45,
X/46, XY. These ﬁndings were consistent with diagnosis of
mixed gonadal dysgenesis [34].
The predominance of the X or XY cell lines determines the
gonadal differentiation into a testis or a streak gonad [35] which
was in line with this patient which had bilateral streak gonads
and 7% male cell lines. In addition, the molecular study deter-
mined the absence of SRY gene (Fig. 4). This suggests that the
deleted SRY gene played a role in maintaining female pheno-
type and Mullerian structures despite the presence of Y
chromosome. The occurrence of mutations in the SRY gene
was reported in patients with 45, X/46XY karyotype [36,37].
During this study, the main challenges were the parents of
the studied cases, who showed marked irritability about their
children’s condition, the spectrum of DSD, which can pose a
diagnostic dilemma and obtaining the material for this study.
The parents were anxious to know their children’s condition
and to reach a diagnosis as soon as possible, whichwasmet from
our side with assurance and need of appropriate full anatomical,
biochemical and multidisciplinary evaluation before rushing to
an arbitrary gender assignment. It was really a challenge.5. Conclusion
The birth of a child with ambiguous genitalia is a matter of a
medical and social emergency. Careful examination of external
genitalia with emphasis on gonadal detection, uniform classiﬁ-
cation of DSD, good cytogenetic and molecular facilities, indi-
vidualized approach with integrated team management and
supportive counseling form the mainstay of management of
DSD. It is also important that appropriate counseling is avail-
able for the individual and family throughout their life and
that the clinical and research communities work together to
256 S.S. AboElella et al.determine the molecular basis of disorders of sex development
when no changes in SOX9, NR5A1 or other candidate genes
are found.
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